powered by LeadingAge New York

Antipsychotic Reduction and Behavioral Management

CMS has announced a major initiative to improve behavioral health management, reduce unnecessary antipsychotic drug use and promote resident-centered care programs. CMS hopes to reduce antipsychotic drug use significantly from current levels for all residents and in particular for residents with dementia.  As part of this initiative DOH surveyors will focus on the following:

  • What are the individualized care and services that are provided to residents with dementia?
  • How will the staff be educated and trained to care for people with dementia, including how to prevent or address the behavioral and psychological symptoms of dementia (BPSD)?
  • What are the processes for the facility to monitor the use of psychopharmacological medications, specifically antipsychotic medications?   

How well does your facility do in caring for residents with dementia?  A LeadingAge New York ProCare Consultant can help.  Our consultant is both a Certified Therapeutic Recreation Specialist and a Licensed Nursing Home Administrator with expertise and experience in the development of quality dementia programs as well as implementing effective staff education strategies. 

For more information, please contact Elliott Frost at 518-867-8832 or email efrost@leadingageny.org.